MF
Marco Fornaro
University of Bari Aldo Moro
Research areas: Medicine · Rheumatology · Rheumatoid Arthritis Research and Therapies · Systemic Sclerosis and Related Diseases · Inflammatory Myopathies and Dermatomyositis
0000-0003-1716-7432
Employment
- 2020 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (36)
- Assessment of CDASI scoring by a multimodal large language model: a comparative study with expert assessors Save
- Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study Save
- Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease–Associated Interstitial Lung Disease: Insights From an Italian Multicenter Cohort Save
- Dermatomyositis is characterized by TYK2-dependent STAT3 activation Save
- Characterizing and Operationalizing the Third Criterion of Difficult-to-Treat Rheumatoid Arthritis: Patient and Physician Perspectives from the GISEA Study Save
- Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers Save
- Serum ferritin as a specific biomarker of anti-MDA5-interstitial lung disease: a multicenter, case–control study in observational and validation datasets Save
- Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies Save
- The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset Save
- Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset Save
- Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry Save
- Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology Save
- Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study Save
- Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis Save
- Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies Save
- Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity Save
- Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients Save
- Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10‐year study from the BIOPURE registry Save
- Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance Save
- Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases Save